THIS IS MORE THAN HOPE
Patients diagnosed with non-Hodgkin lymphoma are told they’ll achieve remission with first-line chemotherapy. But about 50% of them don’t, as their cancer resists treatment after treatment. They are running out of options…and hope. They need a reason to believe complete remission can still exist after treatment failure. YESCARTA is the first CAR T-cell therapy approved for NHL. It can give appropriate 3rd-line patients something more than hope––it can give them a chance for complete remission. With a strategically choreographed ecosystem focused on messages of empowerment and hope, we are able to provide patients the resources they need to fight for their survival.
Our goal was to give patients not only hope, but a chance for real remission. Together, with patients and oncologists, we are all succeeding.
THE CAMPAIGN
The developed campaign is a glimpse into a private moment, when a patient receives the news that they are in remission. This raw snapshot of emotion encapsulates what patients want so dearly for themselves. It helps them believe, they too, can have this moment. With YESCARTA, hope can be tangible and safe once again.
THE POWER OF PATIENT SELF ADVOCACY
Despite a very small patient population, YESCARTA made an outsized impact. These numbers represent more than campaign results—they represent lives saved.
PATIENT POPULATION: 8,400
281,699
UNIQUE SITE VISITS
5,186
DISCUSSION TOOL
DOWNLOADS
13,999
AUTHORIZED TREATMENT
CENTER SEARCHES
EDUCATE AND INSPIRE
A variety of targeted tactics give patients the motivation and information they need to request a referral for CAR T-cell therapy.
The website functions as a hub for engagement with tools to educate patients on their treatment options, and resources to facilitate productive conversations with an oncologist about a treatment referral.
Video content featuring real YESCARTA patients sharing their stories of hope and survival. Shared through social media and display ads to make a relatable connection and drive patients back to the website to view the full story.
Print pieces help patients understand how YESCARTA is different and when it could be an option. Since the NHL treatment journey can be complex, a patient-friendly treatment algorithm explains the different options available in each phase of therapy. This information helps patient understand when it’s appropriate to start requestion YESCARTA.